Genetic Variations Impacting Empathy Tied to Psych Issues

Share this content:
Genetic Variations Impacting Empathy Tied to Psych Issues
Genetic Variations Impacting Empathy Tied to Psych Issues

MONDAY, March 12, 2018 (HealthDay News) -- Genetic variations associated with empathy play a role in psychiatric conditions and traits, including schizophrenia, anorexia nervosa, and extraversion, according to a study published online March 11 in Translational Psychiatry.

Varun Warrier, from the University of Cambridge in the United Kingdom, and colleagues conducted the largest genome-wide association study (GWAS) of empathy to date using the well-validated self-reported Empathy Quotient (EQ). Data were included for 46,861 research participants from 23andMe, Inc.

The researchers identified 11 suggestive loci (P < 1 × 10−6), although after correction for multiple testing, none were significant at P < 2.5 × 10−8. The most significant small nucleotide polymorphism (SNP), an intronic SNP in TMEM132C (rs4882760), was identified in the non-stratified analysis. A modest but significant narrow-sense heritability was found for the EQ. A significant female advantage on the EQ, predicted in earlier work, was confirmed. Between the sexes there was similar SNP heritability and high genetic correlation. There was also a significant negative genetic correlation between autism and EQ, as predicted. A significant positive genetic correlation was identified between the EQ and risk for schizophrenia, risk for anorexia nervosa, and extraversion.

"This is the first GWAS of self-reported empathy. The results suggest that the genetic variations associated with empathy also play a role in psychiatric conditions and psychological traits," the authors write.

One author is an employee of 23andMe, Inc.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »